Glycogen Flashcards

1
Q

Liver glycogen stores

A
  • Glycogen is stored in the fed state to maintain blood glucose when needed
  • Depleted during a fasted state after 12-18 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glycogen

A
  • Glycogenin protein w/ alpha 1,4 glucose chains and alpha-1,6 branch points
  • Glycogenin serves as a primer by glucosylating itself (autoglucosylation). That is, glycogenin via a –OH groups of tyrosine within its structure makes a bond to a glucose. The glucose on glycogenin then further elongates the polysaccharide chain
  • The anomeric carbon that is not attached to another glycosyl residue (the reducing end) is attached to the protein glycogenin by a glycosidic bond via the amino acid tyrosine.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Muscle glycogen stores

A
  • Glycogen is stored to provide energy during prolonged exercise
  • Not affected by short periods of fasting (a few days) and moderately depleted in prolonged fasting (weeks)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Glycogen synthase

A
  • transfers the glucose in UDP glucose to one of the growing glycogen branches forming α-1,4 linkages
  • G6P allosterically partially activates the inactive (phosphorylated) form of glycogen synthase.
  • If glucose levels ⬆️⬆️ in the cell and glycolysis/TCA is going at top speed, but not keeping up with demand, G6P levels⬆️; backup occurs at glycogen synthase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Branching enzyme, 4:6 transferase

A
  • When about 11 glucose molecules are added to one growing chain of glycogen this enzyme moves a chain of 6-8 glucose molecules to form a new branch chain starting with an α-1,6 linkage at the branch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Glycogen Storage Disease Type 0 (GSD 0) molecular basis

A
  • A deficiency in the enzyme glycogen synthase results in very low amounts of glycogen stored in the liver. A person between meals can develop hypoglycemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Glycogen Storage Disease Type 0 (GSD 0) symptoms

A
  • drowsiness, vomiting, fatigue and sometimes convulsions, and look pale
  • muscle cramps from accumulated lactic acid
  • mild growth delay
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Glycogen Storage Disease Type 0 (GSD 0) diagnosis

A
  • liver biopsy will show very little glycogen. DNA testing is available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glycogen Storage Disease Type 0 (GSD 0) treatments

A
  • snacks every 3-4 hours
  • Uncooked cornstarch can act as a ‘slow release’ form of glucose and may prevent hypoglycemia overnight
  • A diet higher than normal in protein may help with the cramping, tiredness and fatigue
  • affects both males and females
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Andersen disease (GSD IV) molecular basis

A
  • Deficient activity of the glycogen-branching enzyme
  • accumulation of abnormal glycogen in the liver, muscle and other tissues
  • autosomal recessive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Andersen disease (GSD IV) symptoms

A
  • In the perinatal variant usually symptoms become apparent in the first few months of a baby’s life
  • failure to thrive - slow growth and failure to gain weight at the expected rate
  • abnormally enlarged liver and spleen
  • progressive liver scarring and liver failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Andersen disease (GSD IV) treatment

A
  • very severe but rare disorder
  • liver transplantation
  • Most children with this condition die before two years of age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adult Polyglucosan Body Disease (APBD) molecular basis

A
  • deficient glycogen- branching enzyme activity, diffuse CNS and peripheral nervous system dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Major principles of metabolic regulation

A
  1. Maximize the efficiency of fuel utilization by preventing the simultaneous operation of opposing pathways (i.e., futile cycles).
  2. Partition metabolites appropriately between alternative pathways.
  3. Draw on the fuel best suited for the immediate needs of the organism.
  4. Shut down biosynthetic pathways when their products accumulate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the physiological effects of insulin on the cell?

A
  • a phosphatase removes a phosphate group on the enzymes and proteins in cells (Covalent modification by dephosphorylation)
  • Insulin, via an insulin factor, activates phosphatases to remove phosphate groups from glycogen phosphorylase, thus INACTIVATING glycogen breakdown
  • Insulin, via an insulin factor, activates phosphatases to remove phosphate groups from glycogen synthase, thus ACTIVATING glycogen synthesis
  • stimulates the uptake of glucose by muscle (Glut-4)
  • When ↑glucose, ↑insulin, ↓glucagon, phosphatases are active
  • stimulates glycogen synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Glycogen phosphorylase

A
  • removes one glucose molecule at a time and converts it to glucose-1-P
  • cannot remove glucose within 4 residues of a branch point (α-1,6 linkage)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Debranching enzyme

A

2 independent active sites catalyzing transferase and glucosidase reactions:

  • 4:4 transferase activity
    • glucosyl transferase
    • removes the three glucose residues (as a trisaccharide) adjacent to the branch point (the α-1,6 linkage) and transfers them to the end of another row
    • 4:4 transferase because the enzyme breaks an α−1,4 bond and forms
      another α−1,4 bond
  • 1:6 glucosidase activity
    • α-1,6-glucosidase or amylo-6-glucosidase
    • removes the α-1,6 glucosidic bond to release one glucose molecule as glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lysosomal degradation of glycogen

A
  • Approximately1-3% of glycogen is degraded by lysosomal enzyme α(1→ 4)- glucosidase
  • involved in debranching and hydrolysis of both α-1,4- and α-1,6-glucosidic linkages at acidic PH of 5 and necessary to break down glycogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Glycogen Storage Disease (GSD) generalities

A
  • genetic disorders characterized by accumulation of abnormal amounts of glycogen primarily due to decreased degradation
  • Synthesis of glycogen occurs in liver and muscle (also minor storage in kidney and intestine) so the GSDs have their primary effect on liver, muscle, RBC, or all
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pompe disease (GSD II) molecular basis

A
  • deficiency of α(1→ 4) glucosidase or α-1,6-glucosidase or acid maltase
  • deficiency in this enzyme results in accumulation of excess amounts of glycogen (normal structure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pompe disease (GSD II) symptoms

A
  • infantile form = death by 2
  • juvenile form = myopathy
  • adult form = MS-like
  • In certain tissues, especially muscles, excessive accumulated glycogen impairs their ability to function normally
  • Massive cardiomegaly: early death from heart failure
  • Normal blood glucose levels
22
Q

Pompe disease (GSD II) diagnosis

A
  • Diagnosed by enzyme assay
23
Q

Pompe disease (GSD II) treatment

A
  • ERT treatment: treated with MYOZYME (alglucosidase alfa); Future gene therapy
24
Q

McArdle Disease (GSD V) molecular

A
  • deficiency of muscle phosphorylase

- most common types of GSD

25
Q

McArdle Disease (GSD V) symptoms

A
  • muscle pain in everyday activities and exercise
  • If activity is prolonged despite the pain then muscle damage ensues with the risk of muscle breakdown and kidney failure
    o Myoglobinuria (myoglobin in urine resulting from serious muscle damage)
    o Rhabdomyolysis (muscle cells breakdown)
    o No rise in lactate during strenuous exercise
    o Normal renal and hepatic development
    o High levels of glycogen with normal structure in muscle
26
Q

McArdle Disease (GSD V) diagnosis

A
  • Diagnosis until the third or fourth decade
  • Later in life some people with McArdle disease experience fixed muscle weakness, possibly from cumulative muscle damage
27
Q

McArdle Disease (GSD V) treatment

A
  • regular aerobic exercise such as walking and avoid anaerobic activities such as lifting heavy weights.
28
Q

Von Gierke’s disease (GSD I) molecular basis

A
  • Deficiency in glucose-6-phosphatase

- Unable to release glucose from liver glycogen

29
Q

Von Gierke’s disease (GSD I)

Symptoms

A
  • sweating, irritability, poor growth and muscle weakness and poor growth during childhood
  • enlarged liver
  • Abnormal accumulation of glycogen (normal structure) in kidney, intestine and liver cells
  • Hyperlacticacidemia (G6P is high; muscle glycolgenolysis high and inc. lactate)
  • frequent mouth ulcers and are at increased risk of infection
30
Q

Von Gierke’s disease (GSD I) Diagnosis

A
  • By DNA testing, enzyme assay and physical examination; a kidney or liver biopsy may be needed for confirmation
31
Q

Von Gierke’s disease (GSD I) Treatment

A
  • Initially glucose via a nasogastric tube. As children get older, glucose is replaced with cornstarch taken orally
32
Q

Her’s disease (GSD VI)

Molecular basis

A
  • Defect in the liver phosphorylase enzyme
  • prevents glucose from being properly extracted and so glycogen continues to accumulate high levels of glycogen with normal structure in liver (hepatomegaly)
33
Q

Her’s disease (GSD VI)

Symptoms

A
  • Clinically similar to Von Gierke disease but typically milder
  • enlarged liver and swollen abdomen and produces symptoms of hypoglycemia
  • Periods of hypoglycemia in GSD VI are milder than other types of GSD as those with type VI can also make glucose from protein
  • poor growth or short stature
  • Episodes of fasting hypoglycemia
  • Excessive tiredness following activity

Potential complications in later life:

  • Cirrhosis and /or adenomas on the liver
  • Pregnancy should be closely monitored

Symptoms lessen as in adults due to lowered energy requirements.

34
Q

Her’s disease (GSD VI)

Diagnosis

A
  • Made on the basis of symptoms and/or following the results of a physical examination and blood test results
35
Q

Her’s disease (GSD VI)

Treatment

A
  • With good dietary management, people can lead a normal life, can have unaffected children and should live into old age
36
Q

Cori/ Forbes disease (GSD III) molecular basis

A
  • deficient activity of glycogen debranching enzyme
  • shorter branches in glycogen
  • liver, heart and skeletal muscle
37
Q

Cori/ Forbes disease (GSD III) symptoms

A
  • Swollen abdomen, low fasting blood glucose, growth delayed during childhood
  • low blood sugar
  • High level of fats in the blood
38
Q

Cori/ Forbes disease (GSD III) Diagnosis

A
  • condition has a wide clinical spectrum
  • Children are often diagnosed because they have been noticed to have a swollen abdomen due to a very large liver
  • Diagnosed by liver biopsy
39
Q

G1P generated from the breakdown of glycogen is converted to glucose-6- phosphate by the action of

A
  • phosphoglucomutase
40
Q

Glucose-6-P is converted to glucose by

A
  • Glucose-6 phosphatase
41
Q

Glucose-6-P cellular location

A
  • highly hydrophobic enzyme embedded in the smooth ER of liver
  • glycogen is located in the cytosol near folds of the smooth ER
  • muscle cannot contribute directly to glucose levels in the blood. There is no glucose-6 phosphatase enzyme present
42
Q

Glycogenesis triggers

A
  • both acute and chronic stress
  • psychological response to acute and chronic threats
  • physiological increase in blood glucose utilization
  • exercise
  • pathological result of blood loss
43
Q

Epinephrine and glucagon receptor locations

A
  • The liver has receptors for both epinephrine and glucagon

- The muscle has receptors for epinephrine

44
Q

Epinephrine and glucagon receptor activation

A
  • activates cyclic AMP (cAMP)
45
Q

Glucagon effect

A
  • Glucagon in fast or starvation and epinephrine in acute stress, stimulate glycogen break down
  • Therefore, inactivating glycogen synthase by phosphorylation and activating glycogen phosphorylase by phosphorylating it
46
Q

Regulation of glycogenolysis in LIVER

A
  • Glucagon acts
    through cAMP and activates protein kinase
  • The net result of phosphorylation by protein kinase is to break down glycogen
    *Glycogen synthase (inactive)
    *Glycogen phosphorylase (GP) kinase (active)
    *GP kinase phosphorylates GP===>Glycogen phosphorylase (active).
47
Q

Regulation of glycogenolysis in MUSCLE

A
  • Regulated by epinephrine (but not by glucagon) via cAMP in the same way glucagon regulates liver glycogenolysis
  • Allosteric regulation
    • AMP levels activate the inactive form of glycogen phosphorylase, causing the enzyme to be more active
    • Calcium ions further activate the inactive form of glycogen phosphorylase kinase, causing the enzyme to be more active.
48
Q

Why are the MUSCLE glycolytic enzymes active during glycogenolysis?

A
  • Epinephrine has the same effects as glucagon (chemical modification- phosphorylation) on the enzymes in the pathways. However in glycolysis:
    *Hexokinase, in the muscle, is the first regulatory enzyme and is constituative. Therefore, a constant physiological level of this enzyme is expressed at all times.
    *Phosphofructokinase-1 (PFK-1) is the second regulatory enzyme. During muscular
    contraction, myosin ATPase increases AMP levels from hydrolysis of ATP to ADP.
    This increase in AMP levels allosterically stimulate glycogenolysis. AMP is an
    allosteric activator of PFK-1. So, AMP activates both glycogenolysis and glycolysis.
    Also the skeletal muscle PFK-2 has no phosphorylation site. It is regulated simply by
    substrate availability, i.e., fructose 6-phosphate (F 6-P). When F 6-P is abundant,
    PFK-2 is active and produces F-2,6-bis phosphate which allosterically activates PFK-1
    (below).
49
Q

Pompe disease early (infantile) onset form symptoms

A

▪ Progressive muscle weakness
▪ Macroglossia (in some cases, protrusion of tongue)
▪ Cardiomegaly (massive) and/or cardiac failure
▪ Splenomegaly

50
Q

Pompe disease Late (juvenile/ adult) onset Form symptoms

A
  • hepatomegaly
  • absence of severe cardiac involvement
  • Greater variation in symptom based on age of onset, clinical presentation, and disease progression